pillbase.ru

Tecentriq Hybreza

Active substance: ATEZOLIZUMAB, HYALURONIDASE (HUMAN RECOMBINANT)

INJECTION · ATEZOLIZUMAB 1875 mg/15mL, HYALURONIDASE (HUMAN RECOMBINANT) 30000 U/15mL

United StatesActive

Marketing holder: Genentech, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Products containing atezolizumab in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
RU 3
  • Тецентрик®
    концентрат для приготовления раствора для инфузий, 60 мг/мл, 20 мл (original in Russian, GRLS)
    ЛП-№(001980)-(РГ-RU)
    Ф.Хоффманн-Ля Рош Лтд
  • Тецентрик®
    раствор для подкожного введения, 1875 мг, 15 мл (original in Russian, GRLS)
    ЛП-№(010982)-(РГ-RU)
    Ф.Хоффманн-Ля Рош Лтд
  • Тецентрик®
    концентрат для приготовления раствора для инфузий, 60 мг/мл, 20 мл (original in Russian, GRLS)
    ЛП-004652
    Ф. Хоффманн-Ля Рош Лтд.
EU 1
  • Tecentriq
    atezolizumab
    EMEA/H/C/004143
    Roche Registration GmbH
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-4439-7546-8a94-f3005e0c57fe,01a120c3-bbd6-71a4-9c06-64452c72e7d2,01a120c5-c3ab-792d-a507-bdf6e6502762;count=3 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12096-00fb-73a8-a7d9-4c4d13163235,01a1209b-0e87-7034-a81e-31d595137842;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
50242-933
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 50242-933 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 50242-933 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 50242-933 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 50242-933 · Verified 2026-10-09 · open in source